You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 21, 2025

Details for Patent: 10,624,911


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,624,911 protect, and when does it expire?

Patent 10,624,911 protects AKYNZEO and is included in one NDA.

This patent has forty-three patent family members in thirty-six countries.

Summary for Patent: 10,624,911
Title:Physiologically balanced injectable formulations of fosnetupitant
Abstract: Injectable dosages and formulations of fosnetupitant and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy.
Inventor(s): Venturini; Alessio (Varese, IT), Cannella; Roberta (Varese, IT)
Assignee: Helsinn Healthcare SA (Lugano/Pazzallo, CH)
Application Number:15/611,785
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,624,911

To conduct a detailed analysis of the scope and claims of a specific patent, such as United States Patent 10,624,911, it is essential to understand the various components and contexts involved in patent analysis. Here’s a comprehensive guide to help you navigate this process.

Understanding the Patent System

Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. It provides various resources and tools to help in patent searches and analyses[2].

Accessing Patent Information

Public Search Facilities

The USPTO Public Search Facility in Alexandria, VA, and the Patent and Trademark Resource Centers (PTRCs) across the country offer access to patent and trademark information. These resources can be crucial for conducting thorough searches and analyses[1].

Patent Search Tools

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, including the IP5 Offices. This service is particularly useful for understanding the global patent family and related applications[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing search results from multiple offices on a single page, which is essential for understanding the patent landscape[1].

Analyzing Patent Claims

Patent Claims Research Dataset

The USPTO provides the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in analyzing claim-level statistics and understanding the scope of patent claims[3].

Types of Patent Allowance Rates

When analyzing patent claims, it is important to consider the different measures of patent allowance rates, such as the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates help in understanding the likelihood of a patent being granted and the complexity of the examination process[4].

Specific Analysis of United States Patent 10,624,911

Patent Details

To analyze the scope and claims of United States Patent 10,624,911, start by accessing the patent details through the USPTO's public search facilities or online databases.

Patent Title and Abstract

Review the title and abstract of the patent to understand the general invention and its purpose.

Claims

Analyze the claims section, which defines the scope of the invention. Claims can be independent or dependent, and understanding their dependency is crucial for determining the patent's scope.

Description and Drawings

The description and drawings provide detailed information about the invention, including its components, functionality, and any specific embodiments.

Claim Construction

Claim construction is a critical step in patent litigation and analysis. It involves interpreting the meaning of the claims to determine their scope. The "Alice" test, for example, is used to determine whether patent claims are directed to abstract ideas and thus not patentable[5].

Prior Art and Citations

Use tools like the Common Citation Document (CCD) to identify prior art cited by various offices. This helps in understanding how the patent differs from existing inventions and its position within the patent landscape[1].

Patent Family and Global Dossier

Examine the patent family using the Global Dossier service to see related applications filed at participating IP Offices. This provides a broader view of the invention's global presence and any related patents or applications[1].

Legal and Litigation Context

Patent Eligibility

Ensure that the patent claims are eligible under Section 101 of the Patent Act. This involves checking if the claims are directed to abstract ideas, laws of nature, or natural phenomena, and if they include elements that transform them into patent-eligible subject matter[5].

Litigation History

Check if the patent has been involved in any litigation. Court decisions can provide valuable insights into how the claims have been interpreted and the patent's validity[5].

Statistical Analysis

Allowance Rates

Use data from the Patent Claims Research Dataset to understand the allowance rates for similar patents. This can provide context on the likelihood of the patent being granted and its standing within its technology field[3].

Continuations and Family Allowance Rates

Analyze the use of continuations and the family allowance rates to understand the complexity and potential outcomes of the patent examination process[4].

Key Takeaways

  • Access to Information: Utilize USPTO resources such as the Public Search Facility, PTRCs, and online databases to access patent information.
  • Claim Analysis: Carefully analyze the claims, description, and drawings to understand the patent's scope.
  • Global Context: Use the Global Dossier and CCD to understand the patent's global family and prior art.
  • Legal Context: Ensure the patent claims are eligible under Section 101 and review any litigation history.
  • Statistical Insights: Use datasets to understand allowance rates and the complexity of the examination process.

FAQs

Q: How can I access the details of United States Patent 10,624,911?

A: You can access the details through the USPTO's public search facilities or online databases such as the USPTO's official website.

Q: What is the significance of the Global Dossier in patent analysis?

A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping to understand the global patent family and related applications.

Q: How do I determine if a patent claim is eligible under Section 101 of the Patent Act?

A: Use the "Alice" test to determine if the claims are directed to abstract ideas and if they include elements that transform them into patent-eligible subject matter.

Q: What are the different types of patent allowance rates, and why are they important?

A: The first-action allowance rate, progenitor allowance rate, and family allowance rate help in understanding the likelihood of a patent being granted and the complexity of the examination process.

Q: Where can I find statistical data on patent claims and allowance rates?

A: The USPTO's Patent Claims Research Dataset provides detailed information on claims and allowance rates for U.S. patents and applications.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. YJOLT - What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. CAFC - CONTOUR IP HOLDING LLC v. GOPRO, INC.: https://cafc.uscourts.gov/opinions-orders/22-1654.OPINION.9-9-2024_2381170.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,624,911

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn Hlthcare AKYNZEO fosnetupitant chloride hydrochloride; palonosetron hydrochloride POWDER;INTRAVENOUS 210493-001 Apr 19, 2018 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Helsinn Hlthcare AKYNZEO fosnetupitant chloride hydrochloride; palonosetron hydrochloride SOLUTION;INTRAVENOUS 210493-002 May 27, 2020 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.